| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/25/2002 | US6410542 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 06/25/2002 | US6410541 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives administered as antitumor agents |
| 06/25/2002 | US6410540 Inhibitors of p38-αkinase |
| 06/25/2002 | US6410539 Imidazole derivatives and their use as farnesyl protein transferase inhibitors |
| 06/25/2002 | US6410537 Brain disorders; antiischemic agents |
| 06/25/2002 | US6410536 Anticoagulants |
| 06/25/2002 | US6410535 Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance |
| 06/25/2002 | US6410534 Anticancer agents |
| 06/25/2002 | US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410531 For therapy of hepatitis c virus (hcv) infection |
| 06/25/2002 | US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 06/25/2002 | US6410529 Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists |
| 06/25/2002 | US6410527 Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| 06/25/2002 | US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents |
| 06/25/2002 | US6410525 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 06/25/2002 | US6410524 Concurrent administering |
| 06/25/2002 | US6410523 Vitamin D derivatives substituted at the 2beta-position |
| 06/25/2002 | US6410522 Anti-depressant, stress suppressor and mood improver |
| 06/25/2002 | US6410521 Nutritional supplements for stimulating bone growth |
| 06/25/2002 | US6410520 Heating in aqueous solution |
| 06/25/2002 | US6410519 Biocompatible device; crosslinked polysaccharides |
| 06/25/2002 | US6410514 Tissue specific prodrug |
| 06/25/2002 | US6410512 Inhibitors of proteasomal activity for stimulating hair growth |
| 06/25/2002 | US6410328 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 06/25/2002 | US6410322 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 06/25/2002 | US6410320 Kidney stem cells; for use in treatment of kidney defects |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410288 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
| 06/25/2002 | US6410281 Reducing corrosion in a fermentor by providing sodium with a non-chloride sodium salt |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410219 Dectionn of pathogen deaction of pathogen by complexing |
| 06/25/2002 | US6410218 Plasma-like solution |
| 06/25/2002 | US6410061 Tea catechins as cancer specific proliferation inhibitors |
| 06/25/2002 | US6410055 Spherical pharmaceutical granules comprising microcrystalline cellulose and a process for their production |
| 06/25/2002 | US6410054 Immediate release eplerenone compositions |
| 06/25/2002 | US6410052 Tea catechins in sustained release formulations as cancer specific proliferation inhibitors |
| 06/25/2002 | US6410049 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
| 06/25/2002 | US6410045 Drug delivery system for antiglaucomatous medication |
| 06/25/2002 | US6410043 Method for chemoprevention of prostate cancer |
| 06/25/2002 | US6410041 Culturing cells in presence of amphipathic weak bases and/or cations and multiple drug resistance inhibitor containing reserpine |
| 06/25/2002 | US6410040 Dissolving poly(2-propenal, 2-propenoic acid) in aqueous base, adding compound containing one or more hydrophobic groups, acidifying solution, whereby interaction between compound and polymer prevents precipitation over broad ph range |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410029 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/25/2002 | US6410021 Vaccines of pasteurellaceae mutants and vaccination method |
| 06/25/2002 | US6410015 Selecting from bone marrow-derived cells population responsive to transforming growth factor beta-1, using as vehicles for transferring genes encoding therapeutic protein to mammal |
| 06/25/2002 | US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene |
| 06/25/2002 | US6410007 Erectile dysfunction, vasodilation |
| 06/25/2002 | US6410006 Ophthalmic composition for keratoconjunctivitis sicca (dry eye) |
| 06/25/2002 | US6409995 Sunscreen |
| 06/25/2002 | US6409992 Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 06/25/2002 | US6409991 Treatment and system for nicotine withdrawal |
| 06/25/2002 | CA2245462C Methods of modulating cell proliferation through telomerase modulation |
| 06/25/2002 | CA2240964C Piperidone tachykinin antagonists |
| 06/25/2002 | CA2234847C Formulation for respiratory tract administration |
| 06/25/2002 | CA2227994C Carbapenem antibiotic, composition and method of preparation |
| 06/25/2002 | CA2220024C Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
| 06/25/2002 | CA2217952C A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 06/25/2002 | CA2215210C Polyphenol fractions of tea, the use thereof and formulations containing them |
| 06/25/2002 | CA2213609C New compounds to modulate hormone receptors, compositions containing them, and their therapeutic use |
| 06/25/2002 | CA2208351C Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 06/25/2002 | CA2203878C Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 06/25/2002 | CA2136893C Substituted n-piperidino-pyrazole-3-carboxamide |
| 06/25/2002 | CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 06/25/2002 | CA2099586C Drug material suitable for micronisation |
| 06/25/2002 | CA2098114C A process for the preparation of diltiazem |
| 06/25/2002 | CA2071981C The use of gaba-b selective agonists as anti-tussive agents |
| 06/25/2002 | CA2058089C Use of substituted 1,2,4-oxadiazole derivatives for combating endoparasites, new substituted 1,2,4-oxadiazole derivatives, and processes for their preparation |
| 06/25/2002 | CA2031384C Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations |
| 06/23/2002 | WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01 |
| 06/23/2002 | CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01 |
| 06/21/2002 | CA2365818A1 Personal care compositions |
| 06/21/2002 | CA2365647A1 Method for reducing the appearance of dark circles under the eyes |
| 06/21/2002 | CA2363799A1 Novel methods for using alkanoyloxymethyl esters |
| 06/20/2002 | WO2002048380A2 Glycosilated cationic lipids for liposomes used in drug delivery |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048348A1 Novel gene existing in human leukocyte antigen domain |
| 06/20/2002 | WO2002048190A1 Use of l-carnitine as stabilizing agent of proteins |
| 06/20/2002 | WO2002048172A2 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
| 06/20/2002 | WO2002048171A1 Methylene steroids as novel androgens |
| 06/20/2002 | WO2002048170A1 Lipids comprising an aminoxy group |
| 06/20/2002 | WO2002048169A1 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile |
| 06/20/2002 | WO2002048166A1 Indolocarbazole anticancer agents and methods of using them |
| 06/20/2002 | WO2002048165A2 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | WO2002048154A2 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 06/20/2002 | WO2002048152A2 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 06/20/2002 | WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 06/20/2002 | WO2002048148A2 Pyrazolopyridine derivatives |
| 06/20/2002 | WO2002048147A2 Pyrazolopyridines |
| 06/20/2002 | WO2002048145A1 Aminotriazolopyridiine derivatives as adenosine receptor ligands |
| 06/20/2002 | WO2002048144A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 06/20/2002 | WO2002048143A2 Antimicrobial 2-pyridones, their compositions and uses |
| 06/20/2002 | WO2002048138A1 Antimicrobial quinolones |
| 06/20/2002 | WO2002048136A1 Keratinocyte proliferation inhibitors |
| 06/20/2002 | WO2002048135A1 Tak1 inhibitors |
| 06/20/2002 | WO2002048134A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | WO2002048131A1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect |
| 06/20/2002 | WO2002048124A2 Piperazine derivatives |
| 06/20/2002 | WO2002048122A2 Benzamidine derivatives |
| 06/20/2002 | WO2002048117A1 Quinazolinone derivatives |